Predicting In Vivo Efficacy of Potential Restenosis Therapies by Cell Culture Studies: Species-Dependent Susceptibility of Vascular Smooth Muscle Cells
Authors:
Open Access
- 30 July 2008
- journal article
- Published by Bentham Science Publishers Ltd. in The Open Cardiovascular Medicine Journal
- Vol. 2 (1) , 60-69
Abstract
Although drug-eluting stents (DES) are successfully utilized for restenosis therapy, the development of local and systemic therapeutic means including nanoparticles (NP) continues. Lack of correlation between in vitro and in vivo studies is one of the major drawbacks in developing new drug delivery systems. The present study was designed to examine the applicability of the arterial explant outgrowth model, and of smooth muscle cells (SMC) cultures for prescreening of possible drugs. Elucidation of different species sensitivity (rat, rabbit, porcine and human) to diverse drugs (tyrphostins, heparin and bisphsophonates) and a delivery system (nanoparticles) could provide a valuable screening tool for further in vivo studies. The anticipated sensitivity ranking from the explant outgrowth model and SMC mitotic rates (porcine>rat>>rabbit>human) do not correlate with the observed relative sensitivity of those animals to antiproliferative therapy in restenosis models (rat≥rabbit>porcine>human). Similarly, the inhibitory profile of the various antirestenotic drugs in SMC cultures (rabbit>porcine>rat>>human) do not correlate with animal studies, the rabbit- and porcine-derived SMC being highly sensitive. The validity of in vitro culture studies for the screening of controlled release delivery systems such as nanoparticles is limited. It is suggested that prescreening studies of possible drug candidates for restenosis therapy should include both SMC cell cultures of rat and human, appropriately designed with a suitable serum.Keywords
This publication has 57 references indexed in Scilit:
- Alendronate-loaded nanoparticles deplete monocytes and attenuate restenosisJournal of Controlled Release, 2006
- Sirolimus and Paclitaxel on Polymer-Based Drug-Eluting StentsJACC, 2006
- Cyclooxygenase-1 Deficiency in Bone Marrow Cells Increases Early Atherosclerosis in Apolipoprotein E– and Low-Density Lipoprotein Receptor–Null MiceCirculation, 2006
- Another attempt to deal with restenosisCatheterization and Cardiovascular Interventions, 2005
- Drug-eluting stents: results, promises and problemsInternational Journal of Cardiology, 2005
- Coronary drug-eluting stent development: Issues in trial designAmerican Heart Journal, 2005
- Drug eluting stents: are human and animal studies comparable?Heart, 2003
- Oral Everolimus Inhibits In-Stent Neointimal GrowthCirculation, 2002
- Macrophage Depletion by Clodronate-Containing Liposomes Reduces Neointimal Formation After Balloon Injury in Rats and RabbitsCirculation, 2002
- Effect of heparin on vascular smooth muscle cells. I. Cell metabolismJournal of Cellular Physiology, 1985